Skip to main content
# Title Department Research Year
11 Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors. Department of Pharmaceutical Organic Chemistry 2024
12 Zirconium-based hydrophobic-MOFs as innovative electrode modifiers for flibanserin determination: Exploring the electrooxidation mechanism using a comprehensive spectroelectrochemical study Department of Pharmaceutical Analytical Chemistry 2024
13 Thunbergiside A: An unprecedented neolignan isolated from Gardenia thunbergia L. f. and the antifungal activity of selected phytochemicals Department of Pharmacognosy 2024
14 Development of an innovative turn-on fluorescent probe for targeted in-vivo detection of nitric oxide in rat brain extracts as a biomarker for migraine disease Department of Pharmaceutical Analytical Chemistry 2024
15 Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation Department of Pharmaceutical Organic Chemistry 2023
16 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
17 Phytoconstituent Isolation and Cytotoxicity Evaluation of the Egyptian Cassia occidentalis L. Possessing Selective Activity against Lung Carcinoma Department of Pharmacognosy 2023
18 Ratiometric fluorometric determination of sulfide using graphene quantum dots and self‑assembled thiolate‑capped gold nanoclusters triggered by aluminum Department of Pharmaceutical Analytical Chemistry 2023
19 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
20 Thiadiazine-2-thione derivatives as new cell- cycle inhibitors Department of Medicinal Chemistry 2023